Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

ClinicalTrials.gov ID: NCT02120027

Public ClinicalTrials.gov record NCT02120027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week, Double-blind, Randomised, Placebo-controlled, Parallel-group Phase III Study With Re-randomisations at Week 25 to Evaluate the Efficacy and Safety of Oral Ibodutant 10 mg Once Daily in Female Patients With Irritable Bowel Syndrome With Diarrhoea (IBS-D)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointestinal disorder characterised by chronic or recurrent abdominal pain or discomfort and diarrhoea. This trial aims at the evaluation of the efficacy and safety of oral ibodutant 10 mg once daily as compared to placebo in women with IBS-D over a 24-week treatment period.

Study identification

NCT ID
NCT02120027
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Menarini Group
Industry
Enrollment
558 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2014 (Type not available)
Primary completion
Nov 2015 (Actual)
Completion
Nov 2015 (Actual)
Last update posted
Mar 3, 2017

2014 – 2015

United States locations

U.S. sites
73
U.S. states
26
U.S. cities
65
Facility City State ZIP Site status
Not listed Chandler Arizona 85224 —
Not listed Glendale Arizona 85308 —
Not listed Mesa Arizona 85202 —
Not listed Phoenix Arizona 85012 —
Not listed Little Rock Arkansas 72211 —
Not listed Little Rock Arkansas 72212 —
Not listed North Little Rock Arkansas 72117 —
Not listed Encino California 91436 —
Not listed Gold River California 95670 —
Not listed Laguna Hills California 92653 —
Not listed Lincoln California 95648 —
Not listed North Hollywood California 91606 —
Not listed Orange California 92868 —
Not listed Pasadena California 91105 —
Not listed San Diego California 92108 —
Not listed Centennial Colorado 80112 —
Not listed Colorado Springs Colorado 80906 —
Not listed Fort Myers Florida 33916 —
Not listed Hialeah Florida 33012 —
Not listed Hialeah Florida 33016 —
Not listed Inverness Florida 34452 —
Not listed Kissimmee Florida 34741 —
Not listed Lauderdale Lakes Florida 33319 —
Not listed Miami Florida 33135 —
Not listed Miami Florida 33165 —
Not listed Miami Florida 33173 —
Not listed Miami Florida 33185 —
Not listed Miami Florida 33186 —
Not listed Miami Lakes Florida 33014 —
Not listed Miami Lakes Florida 33016 —
Not listed Pinellas Park Florida 33782 —
Not listed Tamarac Florida 33319 —
Not listed Tampa Florida 33606 —
Not listed Addison Illinois 60101 —
Not listed Oak Lawn Illinois 60453 —
Not listed Rockford Illinois 61107 —
Not listed Evansville Indiana 47714 —
Not listed Clive Iowa 50325 —
Not listed Shawnee Kansas 66218 —
Not listed Metairie Louisiana 70006 —
Not listed Shreveport Louisiana 71103 —
Not listed Columbia Maryland 21045 —
Not listed Brockton Massachusetts 02301 —
Not listed Brockton Massachusetts 02302 —
Not listed Wyoming Michigan 49519 —
Not listed St Louis Missouri 63128 —
Not listed Billings Montana 59102 —
Not listed Newington New Hampshire 03801 —
Not listed Brooklyn New York 11235 —
Not listed Great Neck New York 11023 —
Not listed New York New York 10016 —
Not listed Hickory North Carolina 28602 —
Not listed High Point North Carolina 27262 —
Not listed Kinston North Carolina 28501-1584 —
Not listed Salisbury North Carolina 28144 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Cincinnati Ohio 45224 —
Not listed Franklin Ohio 45005 —
Not listed Mentor Ohio 44060 —
Not listed Levittown Pennsylvania 19056 —
Not listed Anderson South Carolina 29621 —
Not listed Germantown Tennessee 38138 —
Not listed Jackson Tennessee 38305 —
Not listed Kingsport Tennessee 37660 —
Not listed Arlington Texas 76012 —
Not listed Houston Texas 77074 —
Not listed San Antonio Texas 78229 —
Not listed Logan Utah 84341 —
Not listed Ogden Utah 84405 —
Not listed Sandy City Utah 84094 —
Not listed Lynchburgh Virginia 24502 —
Not listed Seattle Washington 98105 —
Not listed Spokane Washington 99208 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02120027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02120027 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →